Effects of galantamine and donepezil on active and passive avoidance tests in rats with induced hypoxia

Journal of Pharmacological Sciences

Volumn 101, Issue 3, 2006, Pages 199-204

  Dimitrova, Darinka Slavcheva ^a   Getova Spassova, Damianka Peteva ^a,b  

^a MEDICAL UNIVERSITY OF PLOVDIV   (Bulgaria)

^b NONE   (Bulgaria)

Author keywords

Cholinesterase inhibitor; Donepezil; Galantamine; Sodium nitrite induced hypoxia

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; SODIUM NITRITE;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; CHOLINERGIC SYSTEM; COGNITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HYPOXIA; LATENT PERIOD; LEARNING TEST; MALE; MEMORY CONSOLIDATION; NONHUMAN; PASSIVE AVOIDANCE; RAT;

EID: 33746330717     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FPE05006X     Document Type: Article

References (19)

1. Davies KL, Maloney AJ. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet. 1976;2:1403.
2. Poirier J. Evidence that clinical effects of cholinesterase inhibitors are related to potency and targeting of action. Int J Clin Pract Suppl. 2002;127:6-19.
3. Clegg A, Bryant J, Nicholson T. Clinical study of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systemic review. Health Technol Assess. 2001;5:1-137.
4. Barnes CA, Meltzer J, Houston F, Orr G, McGann K, Wenk GL. Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors. Neuroscience. 2000;99:17-23.
5. Samochocki M, Zerlin M, Jostock R, Groot Kormelink PJ, Luyten WH, Albuquerque EX, et al. Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR. Acta Neurol Scand Suppl. 2000;176:68-73.
6. Iliev AI, Traykov VB, Manchev GT, Stoykov I, Prodanov D, Yakimova KS, et al. A post-ischaemic single administration of galantamine, a cholinesterase inhibitor, improves learning ability in rats. J Pharm Pharmacol. 2000;52:1151-1156.
7. Higgins GA, Enderlin M, Fimbel R, Haman M, Grottick AJ, Soriano M, et al. Donepezil reverses a mnemonic deficit produced by scopolamine but not perforant path lesion or transient cerebral ischemia. Eur J Neurosci. 2002;15:1827-1840.
8. Kosasa T, Kuriya Y, Yamanishi Y. Effect of donepezil hydrochloride (E2020) on extracellular acetylcholine concentration in the cerebral cortex of rats. Jpn J Pharmacol. 1999;81:216-226.
9. Hlinak Z, Krejci I. Long-term behavior consequences of sodium nitrite hypoxia: an animal model. Act Nerv Super. 1990;32:48-53.
10. Bhattacharya SK. Nootropic effect of BR-16A (Mentat), a psychotropic herbal formulation on cognitive deficits induced prenatal undernutrition, postnatal environmental improvereshment and hypoxia in rats. Indian J Exp Biol. 1994;1:31-65.
11. Nyakas C, Buwalda B, Kramers RJ, Traber J, Luiten PG. Postnatal development of hippocampal and neocortical cholinergic and serotonergic innervation in rat: effects of nitriteinduced prenatal hypoxia and nimodipine treatment. Neuroscience. 1994;59:541-559.
12. Kožiar VS, Trofimov SS, Ostrovskaia RU, Sariev AK, Zherdev VP. Prenatal exposure to sodium oxybutyrate prevents a disorder of general behavior, learning and memory in the progeny of rats subjected to chronic haemic hypoxia. Eksp Klin Farmakol. 1994;57:8-11.
13. Hlinak Z, Krejci I, Hondlik J, Yamamoto A. Behavioral consequences of sodium nitrite hypoxia in male rats: amelioration with alaptide treatment. Methods Find Exp Clin Pharmacol. 1990;12:385-393.
14. Rakonczay Z. Potencies and selectivities of inhibitors of acetylcholinesterase and its molecular forms in normal and Alzheimer's disease brain. Acta Biol Hung. 2003;54:183-189.
15. Nordberg A, Lundquist H, Hartving P, Lija A, Langstrom B. Kinetic analysis of regional (S)(-)C-nicotine binding in normal and Alzheimer brains: in vivo assessment using positron emission tomography. Alzheimer Dis Assoc Disord. 1995;9:21-27.
16. Peng X, Gerzanich V, Anand R, Wang F, Lindsstrom J. Chronic nicotine treatment upregulates α3 AchRs and α7 AchRs expressed by the human neuroblastoma cell line SH-SY5Y. Mol Pharmacol. 1997;51:776-784.
17. Kihara T, Shimohama S, Urushitani M, Sawada H, Kimura J, Kume T, et al. Stimulation of alpha4beta2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity. Brain Res. 1998;792:331-334.
18. Haǔg KH, Bogen IL, Osmudsen H, Walaas I, Fonnum F. Effects of cholinergic markers in rat brain and blood after short and prolonged administration of donepezil. Neurochem Res. 2005;30:1511-1520.
19. Xu Y, Tian JZ, Sheng SL. [Effect of GETO on expression of protein in postsynaptic dense of Alzheimer's disease model of rats.] Zhogguo Zhong Xi Yi Jie He Za Zhi. 2006;26:54-57. (text in Chinese with English abstract)